Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial

S. Senan; R. Olson; S. Harrow; S. Gaede; A. Louie; C. Haasbeek; L. Mulroy; M. Lock; G. Rodrigues; B. Yaremko; D. Schellenberg; B. Ahmad; G. Griffioen; S. Senthi; M. Liu; K. Moore; S. Currie; G. Bauman; A. Warner; D. Palma

doi:https://doi.org/10.1093/annonc/mdy433

Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial

S. Senan, R. Olson, S. Harrow, S. Gaede, A. Louie, C. Haasbeek, L. Mulroy, M. Lock, G. Rodrigues, B. Yaremko, D. Schellenberg, B. Ahmad, G. Griffioen, S. Senthi, M. Liu, K. Moore, S. Currie, G. Bauman, A. Warner, D. Palma

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Article number	ix170
Journal	Annals of Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy433 https://doi.org/10.1093/annonc/mdy433
Publication status	Published - Nov 2018

Access to Document

Cite this

Senan, S., Olson, R., Harrow, S., Gaede, S., Louie, A., Haasbeek, C., Mulroy, L., Lock, M., Rodrigues, G., Yaremko, B., Schellenberg, D., Ahmad, B., Griffioen, G., Senthi, S., Liu, M., Moore, K., Currie, S., Bauman, G., Warner, A., & Palma, D. (2018). Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial. Annals of Oncology, 29, Article ix170. https://doi.org/10.1093/annonc/mdy433, https://doi.org/10.1093/annonc/mdy433

@article{714285d4fd1d4b7482bd26e8f2cb6e8d,

title = "Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial",

author = "S. Senan and R. Olson and S. Harrow and S. Gaede and A. Louie and C. Haasbeek and L. Mulroy and M. Lock and G. Rodrigues and B. Yaremko and D. Schellenberg and B. Ahmad and G. Griffioen and S. Senthi and M. Liu and K. Moore and S. Currie and G. Bauman and A. Warner and D. Palma",

year = "2018",

month = nov,

doi = "https://doi.org/10.1093/annonc/mdy433",

language = "English",

volume = "29",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Senan, S, Olson, R, Harrow, S, Gaede, S, Louie, A, Haasbeek, C, Mulroy, L, Lock, M, Rodrigues, G, Yaremko, B, Schellenberg, D, Ahmad, B, Griffioen, G, Senthi, S, Liu, M, Moore, K, Currie, S, Bauman, G, Warner, A & Palma, D 2018, 'Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial', Annals of Oncology, vol. 29, ix170. https://doi.org/10.1093/annonc/mdy433, https://doi.org/10.1093/annonc/mdy433

TY - JOUR

T1 - Stereotactic ablative radiotherapy for oligometastatic cancers

T2 - Efficacy and toxicity results from the randomized SABR-COMET Trial

AU - Senan, S.

AU - Olson, R.

AU - Harrow, S.

AU - Gaede, S.

AU - Louie, A.

AU - Haasbeek, C.

AU - Mulroy, L.

AU - Lock, M.

AU - Rodrigues, G.

AU - Yaremko, B.

AU - Schellenberg, D.

AU - Ahmad, B.

AU - Griffioen, G.

AU - Senthi, S.

AU - Liu, M.

AU - Moore, K.

AU - Currie, S.

AU - Bauman, G.

AU - Warner, A.

AU - Palma, D.

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85081608909&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/annonc/mdy433

DO - https://doi.org/10.1093/annonc/mdy433

M3 - Meeting Abstract

SN - 0923-7534

VL - 29

JO - Annals of Oncology

JF - Annals of Oncology

M1 - ix170

ER -

Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial

Access to Document

Other files and links

Cite this